What are the therapeutic implications of these mutations?
The identification of MMR gene mutations has important therapeutic implications. For instance, tumors with high MSI levels tend to respond well to immune checkpoint inhibitors, a type of immunotherapy. Drugs like pembrolizumab and nivolumab have shown efficacy in treating cancers with MMR deficiencies. Additionally, knowing a patient's MMR status can help guide treatment decisions and surveillance strategies.
